BiomX Future Growth
Future criteria checks 0/6
BiomX's earnings are forecast to decline at 24.5% per annum while its annual revenue is expected to grow at 100.3% per year. EPS is expected to decline by 9.8% per annum.
Key information
-24.5%
Earnings growth rate
-9.8%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 100.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -48 | N/A | N/A | 2 |
| 12/31/2025 | N/A | -41 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -30 | N/A | N/A | 2 |
| 9/30/2024 | N/A | -9 | N/A | N/A | N/A |
| 6/30/2024 | N/A | -26 | -35 | -35 | N/A |
| 3/31/2024 | N/A | -34 | -28 | -28 | N/A |
| 12/31/2023 | N/A | -26 | -21 | -21 | N/A |
| 9/30/2023 | N/A | -27 | -22 | -22 | N/A |
| 6/30/2023 | N/A | -25 | -22 | -22 | N/A |
| 3/31/2023 | N/A | -27 | -27 | -27 | N/A |
| 12/31/2022 | N/A | -28 | -29 | -29 | N/A |
| 9/30/2022 | N/A | -33 | -31 | -31 | N/A |
| 6/30/2022 | N/A | -36 | -33 | -31 | N/A |
| 3/31/2022 | N/A | -36 | -31 | -29 | N/A |
| 12/31/2021 | N/A | -36 | -31 | -28 | N/A |
| 9/30/2021 | N/A | -35 | -30 | -26 | N/A |
| 6/30/2021 | N/A | -34 | -29 | -26 | N/A |
| 3/31/2021 | N/A | -33 | -26 | -24 | N/A |
| 12/31/2020 | N/A | -30 | -25 | -24 | N/A |
| 9/30/2020 | N/A | -27 | -25 | -24 | N/A |
| 6/30/2020 | N/A | -23 | -24 | -23 | N/A |
| 3/31/2020 | N/A | -22 | -23 | -21 | N/A |
| 12/31/2019 | N/A | -21 | -19 | -18 | N/A |
| 9/30/2019 | N/A | -22 | -15 | -14 | N/A |
| 6/30/2019 | N/A | -19 | -13 | -12 | N/A |
| 3/31/2019 | N/A | -17 | -12 | -12 | N/A |
| 12/31/2018 | N/A | -15 | -11 | -11 | N/A |
| 12/31/2017 | N/A | -7 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHGE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PHGE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PHGE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PHGE is forecast to have no revenue next year.
High Growth Revenue: PHGE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHGE's Return on Equity is forecast to be high in 3 years time